Australia markets closed

Castle Biosciences, Inc. (CSTL)

NasdaqGM - NasdaqGM Real-time price. Currency in USD
Add to watchlist
24.65-0.35 (-1.40%)
At close: 04:00PM EDT
26.38 +1.73 (+7.02%)
After hours: 05:51PM EDT
Show:
Annual

Income statement

All numbers in thousands
Breakdown
ttm
31/12/2021
31/12/2020
31/12/2019
31/12/2018
Total revenue
110,204
94,085
62,649
51,865
22,786
Cost of revenue
22,727
15,822
9,685
7,310
5,297
Gross profit
87,477
78,263
52,964
44,555
17,489
Operating expenses
Research development
39,632
29,646
13,256
7,385
4,854
Selling general and administrative
115,706
86,738
48,132
29,842
16,470
Total operating expenses
160,785
118,342
59,506
37,227
21,325
Operating income or loss
-73,308
-40,079
-6,542
7,328
-3,836
Interest expense
8
1
2,634
4,571
2,274
Total other income/expenses net
-
-
-1,397
2,280
-272.417
Income before tax
-55,040
-40,012
-10,200
5,349
-6,358
Income tax expense
-10,548
-8,720
84
72
8.606
Income from continuing operations
-44,492
-31,292
-10,284
5,277
-6,367
Net income
-44,492
-31,292
-10,284
5,277
-6,367
Net income available to common shareholders
-44,492
-31,292
-10,284
2,991
-6,095
Basic EPS
-
-1.24
-0.54
0.35
-0.62
Diluted EPS
-
-1.24
-0.54
-0.21
-0.62
Basic average shares
-
25,137
18,929
8,584
9,784
Diluted average shares
-
25,137
18,929
8,658
9,784
EBITDA
-
-36,604
-7,094
10,278
-3,762